NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Lercanidipine


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
New hypertension study findings recently were reported by researchers at University of Cambridge
2009 SEP 7 ... assigned to receive 1 of the following 4 antihypertensive agents: perindopril, atenolol, lercanidipine, or bendrofluazide. BP was measured using a mercury sphygmomanometer, and augmentation ...
Subject: Hypertension
Price: $3.00
*
Research from University of Malaya, Medical Department provides new data on adverse drug reactions
2009 SEP 14 ... "One reason is poor tolerability due to adverse events. Racial differences also exist. Lercanidipine, a third-generation calcium channel blocker, is associated with better tolerability. ...
Subject: Adverse Drug Reactions
Price: $3.00
*
Studies from C. Chatzikyrkou and colleagues yield new information about hypertension
2009 SEP 28 ... concluded: "Of note, the once-daily administration of a fixed-dose enalapril/lercanidipine, by bringing together two distinct and complementary mechanisms of action, reduces BP ...
Subject: Hypertension
Price: $3.00
*
Studies from V.B. Boralli et al provide new data on pharmacokinetics
2009 MAR 9 ... 'Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers,' are discussed in a new report. "Hypertension and ...
Subject: Pharmacokinetics
Price: $3.00
*
Data on diabetes therapy reported by researchers at Tel-Aviv University
2007 JUL 16 ... Research findings, "Effect of lercanidipine on kidney microanatomy in cohen-rosenthal diabetic hypertensive rats," are discussed in ...
Subject: Diabetes Therapy
Price: $3.00
*
LifeCycle Pharma A/S Announces Successful Completion of Pilot Studies on LCP-Feno and is Currently Preparing for Pivotal Studies
2008 JUN 9 ... service agreement which encompasses the development of a novel version of Recordati's lercanidipine (Zanidip(R)) for the treatment of hypertension. In addition, LifeCycle Pharma and Sciele ...
Subject: LifeCycle Pharma A/S
Price: $3.00
*
New data from Tel-Aviv University, Israel, studies illuminate research
2007 OCT 9 ... directions of research. Study 1: Research findings, "Effect of lercanidipine on kidney microanatomy in cohen-rosenthal diabetic hypertensive rats," are discussed in ...
Subject: Tel-Aviv University, Israel
Price: $3.00
*
New diabetes animal studies study findings recently were published by M.L. Martinez and co-researchers
2008 DEC 29 ... Research findings, 'Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular ...
Subject: Diabetes Animal Studies
Price: $3.00
*
New experimental design study findings have been reported by I. Popovic and colleagues
2008 APR 22 ... software have been used to optimize a liquid chromatographic method for separation of lercanidipine and its three impurities," scientists in Serbia report. "In both ...
Subject: Experimental Design
Price: $3.00
*
Reports from Meda highlight the latest developments
2007 AUG 6 ... agreement for marketing Zaneril on the German market. Zaneril combines the substances lercanidipine and enalapril. Zaneril is well documented and indicated for treatment of high blood ...
Subject: Meda
Price: $3.00
*
Research from National Taiwan University in dialysis provides new insights
2008 DEC 29 ... According to a study from Taipei, Taiwan, "Lercanidipine is a lipophilic calcium channel blocker and a widely used antihypertensive agent. ...
Subject: Dialysis
Price: $3.00
*
Researchers from University of Insubria detail new studies and findings in the area of angiotensins
2008 MAR 17 ... with LV concentric hypertrophy were randomized to ramipril + candesartan or ramipril + lercanidipine. Before and after the 6-month treatment they underwent a 24-h blood pressure (BP) ...
Subject: Angiotensins
Price: $3.00
*
Study data from V. Barrios and co-authors update knowledge of clinical practice
2008 JUN 5 ... CondicionEs normales de uso study was aimed to compare the tolerability of high doses of lercanidipine with amlodipine and nifedipine gastro-intestinal therapeutic system (GITS) in the ...
Subject: Clinical Practice
Price: $3.00
*
Study findings from La Paz University broaden understanding of blood pressure
2007 DEC 31 ... Scientists discuss in 'Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: ...
Subject: Blood Pressure
Price: $3.00
*
Study findings on angiotensins are outlined in reports from University of New South Wales, Research Department
2008 APR 14 ... candesartan and telmisartan (A2RAs; 10%-20% better), perindopril (ACEI; 25% better) and lercanidipine (CCB; 25% better). Median MPRs were generally around 100%, indicating that most patients ...
Subject: Angiotensins
Price: $3.00
*
Study findings on drug research are outlined in reports from J. Menne and colleagues
2008 JUL 22 ... "The dihydropyridine calcium channel blocker lercanidipine and the ACE inhibitor enalapril are frequently used in the treatment of hypertensive ...
Subject: Drug Research
Price: $3.00
*
University of Sao Paulo, Faculty of Medicine of Ribeirao Preto publishes research in hypertension animal studies
2008 SEP 22 ... Research findings, 'Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in ...
Subject: Hypertension Animal Studies
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login